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Abstract 
 
A 63-year-old woman with typical chest pain referred to our center. Her risk factors were hypertension (HTN), 
hyperlipidemia (HLP), diabetic mellitus (DM), and smoking. Coronary angiography (CAG) revealed a tubular 
lesion (95%) in proximal part, and a diffuse lesion (95%) in the mid part of left anterior descending (LAD) with 
a  good  distal  flow.  Stenting  of  proximal  and  mid  part  lesion  was  done  for  her  with  2  drug-eluting  stent 
(paclitaxel-eluting coronary stent system, EURoCOR) with success. After 6 days, due to a typical chest pain 
without response to medications, the coronary angiography was performed showing a definite fracture of stent 
which was implanted in the mid part of left anterior descending artery (LAD) 6 days before admission. 
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Introduction 
 
Stent fracture is one of the possible causes of rest en-
osis after drug eluting stent (DES) implantation. Stent 
fracture is likely affected by mechanical stresses pro-
voked by rigid structures and hinge points; also stent 
fracture might be associated with the high incidence 
of target lesion revascularization. Stent fractures have 
been reported as rare complications. In one study, the 
incidence of stent fracture was 3.2%
1 and in another 
was 2.6%.
2 
Stent fracture is known to occur in several condi-
tions including in terms of vessel, fractures of stent 
are subject to develop in the area of increased rigidi-
ty (for example, stent fracture is found in the point 
of the maximal vessel curvature, overlapping site of 
stents, and tortuous vessels or calcified lesions) and 
from the point of procedure, long stent implantation 
and larger balloon at high pressure tend to fracture 
the stent.
3 
 
 
Case Report 
 
The  patient  was  a  63-year-old  woman  with  typical 
chest pain. she suffered from risk factors of hyperten-
sion (HTN), hyperlipidemia (HLP), diabetic mellitus 
(DM), and smoking. She did not have any abnormali-
ty in her physical examination. The biochemical test 
results,  including  cardiac  enzymes  were  all  within 
normal limits. Her baseline electrocardiogram was a 
normal sinus rhythm with left bundle branch block 
(LBBB).  Transthoracic  echocardiography  showed  a 
40% ejection fraction, left ventricular dilatation with 
hypokinesia in the lateral walls and dyskinesia of sep-
tal and apical walls. 
She underwent Coronary angiography (CAG) that 
revealed a tubular lesion (95%) in the proximal left 
anterior descending artery (LAD), and a diffuse le-
sion (95%) in mid part of LAD with a good distal 
flow. Stenting of proximal lesion with a 3 mm x 19 
mm,  paclitaxel-eluting  coronary  stent  system  (EU-
RoCOR), and mid part of lesion with a 2.5 mm x 32 
mm  paclitaxel-eluting  coronary  stent  system  (EU-
RoCOR) was carried out for her with success. After 
stenting, coronary angiography showed good deposi-
tion of stent with a good distal flow (TIMI3) (Figure 
1).  Afte  6  days,  the  patient  referred  with  a  typical 
chest  pain  without  any  response  to  medication.  
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Fig. 1: Coronary angiography after stenting shows a 
good deposition of stent 
 
Coronary angiography was done for her and showed 
an optimal extent expansion without any significant 
residual stenosis.  However, we detected the definite 
fracture of stent, which was implanted in the mid part 
of LAD 6 days before her admission (Figure 2). 
 
Discussion 
 
As drug-eluting stents greatly reduce the risk of in-
stent rest enosis (ISR), it has been used extensively 
and may be used much more in the future.
3 Stent frac-
tures were shown as rare complications and several 
cases of drug-eluting stent (DES) fracture have been 
reported.
4-6 They are germane to long coronary stents 
that became more prevalent with the advent of drug-
eluting stents  curbing  the  fear  of  long  in-stent  rest 
enosis.  In  one  study  the  significant  multivariate  
predictors of stent fracture were the stent length and 
the right coronary artery (RCA) location. The length 
of gap between the fractured segments and the time of 
stent fracture may contribute the ISR. Stent fractures 
are found in point of the maximal vessel curvature, 
overlapping site of stents, tortuous vessels, calcified 
lesions, long stent implantation and larger balloon at 
high  pressure.
3  Stent  fractures  were  previously  re-
ported several months after the follow-up of coronary 
angiographies, and the exact time when the stent frac-
ture occurred was not tracked, but recently it has been 
reported until  2  days  after  syfer  eluting  stent(SES) 
depvelopment.
3 We report a case with stent fracture 
in mid part of LAD within 6 days after paclitaxel-
eluting coronary stent deployment. 
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Fig. 2: Coronary angiography 6 days after stent im-
plantation shows the stent fracture (arrow) 